The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2020, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2020-02-25
DOI
10.1155/2020/4638192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
- (2019) Zongmin Zhao et al. ADVANCED DRUG DELIVERY REVIEWS
- An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- (2019) Imane El Dika et al. ONCOLOGIST
- Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis
- (2019) Federico Colombo et al. JOURNAL OF AUTOIMMUNITY
- The Blood Clearance Kinetics and Pathway of Polymeric Micelles in Cancer Drug Delivery
- (2018) Xuanrong Sun et al. ACS Nano
- Directing Nanoparticle Biodistribution through Evasion and Exploitation of Stab2-Dependent Nanoparticle Uptake
- (2018) Frederick Campbell et al. ACS Nano
- Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
- (2018) G K Abou-Alfa et al. ANNALS OF ONCOLOGY
- Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma
- (2018) Xiaolong Tang et al. DRUG DELIVERY
- Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects
- (2018) João C. Fernandes DRUG DISCOVERY TODAY
- Production of human single-chain fragment antibody (ScFv) against human epidermal growth factor receptor-2 (HER-2) by phage display technology
- (2018) Saeideh Foroumadi et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Preferential hepatic uptake of paclitaxel-loaded poly-( d - l -lactide- co -glycolide) nanoparticles — A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution
- (2018) Dipika Mandal et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Factors relating to the biodistribution & clearance of nanoparticles & their effects on in vivo application
- (2018) Yanchun Wei et al. Nanomedicine
- Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art
- (2018) Antonio Facciorusso WORLD JOURNAL OF GASTROENTEROLOGY
- Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles
- (2018) Anirudh Sharma et al. Scientific Reports
- The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery
- (2018) Matthias Bros et al. Frontiers in Immunology
- Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma
- (2018) Ryan L. Setten et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Clearance in Drug Design
- (2018) Dennis A. Smith et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model
- (2017) Francesca Marano et al. ENDOCRINE-RELATED CANCER
- Protein corona: a new approach for nanomedicine design
- (2017) Van Hong Nguyen et al. International Journal of Nanomedicine
- New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma
- (2017) Cristian Turato et al. JOURNAL OF CONTROLLED RELEASE
- Liver sinusoidal endothelial cells: Physiology and role in liver diseases
- (2017) Johanne Poisson et al. JOURNAL OF HEPATOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery
- (2017) Svetlana T Yurkin et al. Nanomedicine
- Recent advances in hepatocellular carcinoma therapy
- (2017) Rinku Dutta et al. PHARMACOLOGY & THERAPEUTICS
- Effect of removing Kupffer cells on nanoparticle tumor delivery
- (2017) Anthony J. Tavares et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Liver Sinusoidal Endothelial Cell: An Update
- (2017) Ana Maretti-Mira et al. SEMINARS IN LIVER DISEASE
- Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage
- (2017) Paolo Durigutto et al. Frontiers in Immunology
- Metabolic zonation of the liver: The oxygen gradient revisited
- (2017) Thomas Kietzmann Redox Biology
- Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona
- (2016) Krishnendu Saha et al. ACS Nano
- Protein bio-corona: critical issue in immune nanotoxicology
- (2016) Monica Neagu et al. ARCHIVES OF TOXICOLOGY
- Polymeric Micelles with Uniform Surface Properties and Tunable Size and Charge: Positive Charges Improve Tumor Accumulation
- (2016) Tong Shen et al. BIOMACROMOLECULES
- Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin
- (2016) Xiaoran Zhang et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo
- (2016) Min-Chen Liu et al. International Journal of Nanomedicine
- Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
- (2016) Min Li et al. International Journal of Nanomedicine
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
- (2016) Yi-Nan Zhang et al. JOURNAL OF CONTROLLED RELEASE
- The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery
- (2016) Claudia Corbo et al. Nanomedicine
- Cellular distribution of injected PLGA-nanoparticles in the liver
- (2016) Jin-Kyu Park et al. Nanomedicine-Nanotechnology Biology and Medicine
- Mechanism of hard-nanomaterial clearance by the liver
- (2016) Kim M. Tsoi et al. NATURE MATERIALS
- Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo
- (2016) Fangfang Chen et al. Nature Nanotechnology
- Arginine dependence of tumor cells: targeting a chink in cancer’s armor
- (2016) M D Patil et al. ONCOGENE
- Doxorubicin–transferrin conjugate triggers pro-oxidative disorders in solid tumor cells
- (2016) Marzena Szwed et al. TOXICOLOGY IN VITRO
- Deconvoluting hepatic processing of carbon nanotubes
- (2016) Simone Alidori et al. Nature Communications
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma
- (2016) Yi-Fan Zhang et al. Scientific Reports
- In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
- (2015) Hamed Arami et al. CHEMICAL SOCIETY REVIEWS
- A novel antibody targeting CD24 and hepatocellular carcinoma in vivo by near-infrared fluorescence imaging
- (2015) Hua He et al. IMMUNOBIOLOGY
- Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin
- (2015) Omar Mezghrani et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Surface modification and local orientations of surface molecules in nanotherapeutics
- (2015) Md. Lutful Amin et al. JOURNAL OF CONTROLLED RELEASE
- Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM
- (2015) Minghua Lv et al. MEDIATORS OF INFLAMMATION
- Nanoparticle uptake: The phagocyte problem
- (2015) Heather Herd Gustafson et al. Nano Today
- Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies
- (2015) Cristina Fornaguera et al. Nanoscale
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Trojan horses and guided missiles: targeted therapies in the war on arthritis
- (2015) Mathieu Ferrari et al. Nature Reviews Rheumatology
- Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma
- (2015) Jaleh Varshosaz WORLD JOURNAL OF GASTROENTEROLOGY
- Co-delivery of siRNA and paclitaxel into cancer cells by hyaluronic acid modified redox-sensitive disulfide-crosslinked PLGA–PEI nanoparticles
- (2015) Yan Shen et al. RSC Advances
- Diagnostic imaging and therapeutic application of nanoparticles targeting the liver
- (2015) Haolu Wang et al. Journal of Materials Chemistry B
- Merging Worlds of Nanomaterials and Biological Environment: Factors Governing Protein Corona Formation on Nanoparticles and Its Biological Consequences
- (2015) Parisa Foroozandeh et al. Nanoscale Research Letters
- Rational Design of Antirheumatic Prodrugs Specific for Sites of Inflammation
- (2015) Shimobi C. Onuoha et al. Arthritis & Rheumatology
- Protein Interactions with Polymer Coatings and Biomaterials
- (2014) Qiang Wei et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice
- (2014) P Macor et al. LEUKEMIA
- Fc Receptors for Immunoglobulins and Their Appearance during Vertebrate Evolution
- (2014) Srinivas Akula et al. PLoS One
- Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesisin vivo
- (2013) Vikash Reebye et al. HEPATOLOGY
- Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery
- (2013) Yuangang Yuangang Zu et al. International Journal of Nanomedicine
- Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials
- (2013) Ruibing Wang et al. Journal of Nanomaterials
- Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5
- (2013) Paolo Durigutto et al. PLoS One
- New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles
- (2013) Nelly Mezzaroba et al. PLoS One
- Identification of transferrin receptor 1 as a hepatitis C virus entry factor
- (2013) D. N. Martin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells
- (2013) Bing He et al. Drug Design Development and Therapy
- Physicochemical Properties Determine Nanomaterial Cellular Uptake, Transport, and Fate
- (2012) Motao Zhu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Visualizing Dynamics of Sub-Hepatic Distribution of Nanoparticles Using Intravital Multiphoton Fluorescence Microscopy
- (2012) Shih-Hsun Cheng et al. ACS Nano
- Targeted Chemo-Photothermal Treatments of Rheumatoid Arthritis Using Gold Half-Shell Multifunctional Nanoparticles
- (2012) Sun-Mi Lee et al. ACS Nano
- The scavenger endothelial cell: a new player in homeostasis and immunity
- (2012) Karen Kristine Sørensen et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5
- (2012) Paolo Macor et al. ARTHRITIS AND RHEUMATISM
- CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma
- (2012) Lina Wang et al. BIOMATERIALS
- Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma
- (2012) Lili Shi et al. BIOMATERIALS
- Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library
- (2012) Yonghai Li et al. BMC BIOTECHNOLOGY
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
- (2012) Anu Puri et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2012) EUROPEAN JOURNAL OF CANCER
- Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
- (2012) Ganesh Venkatraman et al. International Journal of Nanomedicine
- Physicochemical Characteristics of Nanoparticles Affect Circulation, Biodistribution, Cellular Internalization, and Trafficking
- (2012) Xiaopin Duan et al. Small
- The Role of Glypicans in Wnt Inhibitory Factor-1 Activity and the Structural Basis of Wif1's Effects on Wnt and Hedgehog Signaling
- (2012) Andrei Avanesov et al. PLoS Genetics
- The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles
- (2011) Kai Xiao et al. BIOMATERIALS
- Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy
- (2011) Chuangnian Zhang et al. BIOMATERIALS
- Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment
- (2011) Anil Kumar et al. BIOMATERIALS
- Nanotechnology for therapy and imaging of liver diseases
- (2011) L. Harivardhan Reddy et al. JOURNAL OF HEPATOLOGY
- Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid
- (2011) Qin Tian et al. Nanomedicine-Nanotechnology Biology and Medicine
- Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
- (2011) Suphiya Parveen et al. Nanomedicine-Nanotechnology Biology and Medicine
- Structure of the protein core of the glypican Dally-like and localization of a region important for hedgehog signaling
- (2011) Min-Sung Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery
- (2010) Qin Tian et al. BIOMATERIALS
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
- (2010) A Santoro et al. BRITISH JOURNAL OF CANCER
- Doxorubicin-Loaded QuadraSphere Microspheres: Plasma Pharmacokinetics and Intratumoral Drug Concentration in an Animal Model of Liver Cancer
- (2010) Kwang-Hun Lee et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Therapeutic Nanoparticles to Combat Cancer Drug Resistance
- (2010) Che-Ming Hu et al. CURRENT DRUG METABOLISM
- Structure and function of immunoglobulins
- (2010) Harry W. Schroeder et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A poly(γ-glutamic acid)–amphiphile complex as a novel nanovehicle for drug delivery system
- (2010) Tetsuyuki Akao et al. JOURNAL OF DRUG TARGETING
- Comparative Study of Chemoembolization Loadable Beads: In vitro Drug Release and Physical Properties of DC Bead and Hepasphere Loaded with Doxorubicin and Irinotecan
- (2010) Olivier Jordan et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases
- (2010) Lanjuan Li et al. Nano Today
- Antibody Vectors for Imaging
- (2010) Tove Olafsen et al. SEMINARS IN NUCLEAR MEDICINE
- Tissue-Level Modeling of Xenobiotic Metabolism in Liver: An Emerging Tool for Enabling Clinical Translational Research
- (2009) Marianthi G. Lerapetritou et al. CTS-Clinical and Translational Science
- Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
- (2009) Adam D. Judge et al. JOURNAL OF CLINICAL INVESTIGATION
- Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium
- (2009) Bård Smedsrød et al. LIVER INTERNATIONAL
- Protracted elimination of gold nanoparticles from mouse liver
- (2009) Evaldas Sadauskas et al. Nanomedicine-Nanotechnology Biology and Medicine
- Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles
- (2009) Zhi Yang et al. NANOTECHNOLOGY
- Preparation of Sodium Deoxycholate (DOC) Conjugated Heparin Derivatives for Inhibition of Angiogenesis and Cancer Cell Growth
- (2008) Kwang Jae Cho et al. BIOCONJUGATE CHEMISTRY
- Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
- (2008) Jong-Ho Kim et al. JOURNAL OF CONTROLLED RELEASE
- New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting
- (2008) P. Chytil et al. JOURNAL OF CONTROLLED RELEASE
- In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy
- (2008) Marites P. Melancon et al. MOLECULAR CANCER THERAPEUTICS
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
- Shape Induced Inhibition of Phagocytosis of Polymer Particles
- (2008) Julie A. Champion et al. PHARMACEUTICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started